Study on the Relationship Between the Number of Adverse Drug Reactions of Essential Drugs and Visits: Based on Vector Autoregressive Model

References

• The central people`s government of the people`s republic of China. What does essential drugs mean?[EB/OL]. Available from: https://www.gov.cn/ztzl/ygzt/content_1661317.htm. Accessed June 8, 2021.
   Google Scholar
• Zhao Y. Research on the national essential drugs list of China in 2018[D]. Zhengzhou University. 2019.
   Google Scholar
• National medical products administration. Implementation Opinions on Establishing a national Essential drugs system[EB/OL]. Available from: https://www.nmpa.gov.cn/directory/web/nmpa/zhuanti/lshzht/shhwshgg/20090818151301303.html. Accessed October 23, 2019.
   Google Scholar
• Rossdegnan D, Ball D, Ewen M, et al. Medicine Prices, Availability, and Affordability in 36 Developing and Middle-Income Countries: a Secondary Analysis. Lancet. 2009;373(9659):240–249.
   PubMed Web of Science ®Google Scholar
• Sheikh K, Gilson L, Agyepong IA, et al. Building the Field of Health Policy and Systems Research: framing the Questions. PLoS Med. 2011;8(8):e1001073. doi:10.1371/journal.pmed.1001073
   PubMed Web of Science ®Google Scholar
• Ye L, Hu SL, Ewen M, et al. Evidence-base study on the affordability of essential drugs in Shanghai. Chine Health Resources. 2008;11(4):195–196.
   Google Scholar
• Zhang Y, Li X. Investigation and analysis of availability and affordability of essential medicine in Nanjing based on WHO/ HAI standard survey method. China Pharm. 2015;26(30):4188–4191.
   Google Scholar
• Gong SW, Xu Y, Zhang L. Study on evaluation indicator system of drug accessibility. Chin Health Economics. 2011;30(5):72–74.
   Google Scholar
• Guan XD, Shi LW. Study on evaluation method for the accessibility of essential medicine in China based on WHO/HAI standardized approach. China Pharm. 2013;24(24):2212–2215.
   Google Scholar
• Wu YX, Xu W, Cai GJ, et al. Study on the factors affecting the availability of essential drugs——An empirical analysis based on data from 25 provinces. Health Economics Research. 2018;4(12):37–39.
   Google Scholar
• Yao Q, Luo F, He LY, et al. Effectiveness evaluation of national essential medicine system in China from the perspective of drug access. Chinese Hospital Management. 2014;34(3):60–62.
   Google Scholar
• Shang JX, Lin QM, Li L, et al. Analysis of rational use of essential medicine in Beijing. Chine Pharm Affairs. 2015;29(10):1006–1012.
   Google Scholar
• National center for ADR monitor. China, Center for drug reevaluation. NIMPA. Drugs-Safety Alert-Data release. Available from: https://www.cdr-adr.org.cn/drug_1/aqjs_1/drug_aqjs_sjbg/. Accessed June 21, 2021.
   Google Scholar
• National Medical Products Administration. National adverse drug reaction monitoring annual report(2020) [EB/OL]. Available from: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20210325170127199.html. Accessed June 21, 2021.
   Google Scholar
• National Bureau of Statistics. National Economic and Social Development Statistical Bulletin[BE/OL]. Available from: http://www.stats.gov.cn/tjsj/tjgb/ndtjgb/. Accessed June 21, 2021.
   Google Scholar
• Ma HH. EViews Statistical Analysis and Application (Third Edition). Beijing: Publishing house of electronics industry; 2016:159–176.
   Google Scholar
• Fossouo Tagne J. Measures for the management of adverse drug reaction reporting and monitoring. China Pharm. 2011;5:68–75.
   Google Scholar
• Jiang C, Shen J, Shou D, et al. Identification of high-risk patients for ADR induced by traditional Chinese medicine injection: a nested case-control study. Sci Rep. 2019;9(1):16721. doi:10.1038/s41598-019-53267-2
   PubMedGoogle Scholar
• Sugioka M, Tachi T, Mizui T, et al. Effects of the number of drugs used on the prevalence of adverse drug reactions in children. Sci Rep. 2020;10(1):21341. doi:10.1038/s41598-020-78358-3
   PubMed Web of Science ®Google Scholar
• Huang P, Wang J. Analysis of 30399 cases of national essential medicine adverse reaction reports. Anhui Med Pharmaceutial J. 2012;16(11):1708–1710.
   Google Scholar
• Chang HH, Chiang SY, Chen PC, et al. A system for reporting and evaluating adverse drug reactions of herbal medicine in Taiwan from 1998 to 2016. Sci Rep. 2021;11(1):21476. doi:10.1038/s41598-021-00704-w
   PubMed Web of Science ®Google Scholar
• Yan Z, Feng Z, Jiao Z, et al. The severity of adverse drug reactions and their influencing factors based on the ADR monitoring center of Henan Province. Sci Rep. 2021;11(1):20402. doi:10.1038/s41598-021-99908-3
   PubMed Web of Science ®Google Scholar
• Liu CL, Xia DS. Discussion on the monitoring of the adverse reaction and the risk management of essential medicines. Chine J Pharmacovigilance. 2014;11(10):614–617.
   Google Scholar
• Kuhn M, Al. Banchaabouchi M, Campillos M, et al. Systematic identification of proteins that elicit drug side effects. Mol Sys Biol. 2013;9(1):663. doi:10.1038/msb.2013.10
   PubMedGoogle Scholar
• Yan S, Xiong H, Shao F, et al. HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions. Pharmacogenomics J. 2019;19(3):277–285. doi:10.1038/s41397-018-0051-3
   PubMed Web of Science ®Google Scholar
• Gao TM, Chen F, Kong XL, et al. Econometric Analysis Methods and Modeling: Eviews Applications and Examples. Beijing: Tsinghua University Press; 2020.
   Google Scholar
• Yu D, Li Y, Tian GC. Empirical analysis of RMB exchange rate based on vector autoregressive model. Modern Business Trade Industry. 2011;23(03):161.
   Google Scholar
• Allen PG, Morzueh BJ. Twenty-five years of progress, problems, and conflicting evidence in econometric forecasting. What about the next 25 years? Int J Forecasting. 2006;22(3):475–492. doi:10.1016/j.ijforecast.2006.03.003
   Web of Science ®Google Scholar
• Han JP, Shao ZX, Wu HZ. Analysis on the Economic Efficiency and Its Influencing Factors of General Hospitals in China Based on VAR Model. Chin Health Economics. 2020;39(1):80–82.
   Google Scholar
• Cheng Y. A study on factors affect China`s price fluctuation in open economy[D]. Xiamen University. 2009:31.
   Google Scholar
• Zhu HM, Liu ZW. Bayesian inference theory of time-series vector autoregressive models. Statistics Decision. 2004;1:11–12.
   Google Scholar
• Su GH, Jiang H. Factors affecting adverse drug reactions. Heilongjiang Sci Tech Information. 2009;7:176.
   Google Scholar
• Jia YL. Briefly discuss the influencing factors and countermeasures of adverse drug reactions. J Front Med. 2016;6(1):384–385.
   Google Scholar
• Zhang SS, Wu T, Zhang R, et al. Interpretation of the 2018 edition of the national essential drugs list. Health Economics. 2019;36(6):47–50.
   Google Scholar